Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
A2Z Venture is a seed-stage venture capital firm founded in 2022, based in Canada. The firm is dedicated to investing in and partnering with entrepreneurs in the healthcare sector, focusing on creating market-leading healthcare service businesses. A2Z Venture aims to significantly improve healthcare by leveraging artificial intelligence technologies.
The firm collaborates with various medical institutions, corporate strategic partners, and other venture capital firms to support its portfolio companies. A2Z Venture's commitment to healthcare innovation positions it as a key player in the Canadian venture capital landscape.
A2Z Venture invests primarily in early-stage companies, specifically targeting pre-seed and seed-stage businesses within the healthcare sector. The firm emphasizes startups that utilize artificial intelligence technologies to drive innovation in healthcare. Key focus areas include AI in Medicine, Artificial Intelligence Data Analytics, AI adoption, Machine Learning for disease diagnosis and prognosis using Medical Imaging, Digital Pathology, and Human-AI Interface in Radiology Imaging Informatics.
The firm seeks to develop sustainable and scalable healthcare enterprises, aiming to create significant improvements in healthcare delivery and outcomes through the application of advanced AI technologies.
A2Z Venture collaborates with various medical institutions and corporate strategic partners to support its portfolio companies. While specific notable portfolio companies or case studies were not provided, the firm's focus on AI-driven healthcare innovations suggests a commitment to backing startups that are pioneering advancements in this critical sector.
Through these collaborations, A2Z Venture aims to enhance the capabilities and reach of its portfolio companies, ensuring they have the necessary resources and support to thrive in the competitive healthcare landscape.
Chris Anderson - Founder and Chairman. Chris has a background in venture capital and healthcare innovation, with experience in leading investments in early-stage healthcare startups. His expertise lies in identifying promising technologies and business models that can significantly impact the healthcare sector.
What investment criteria does A2Z Venture look for?
A2Z Venture focuses on early-stage companies in the healthcare sector that leverage artificial intelligence technologies. They specifically target pre-seed and seed-stage businesses.
How can I pitch A2Z Venture?
Founders can reach out through the firm's website for inquiries. A detailed pitch deck highlighting the startup's AI applications in healthcare is recommended.
What makes A2Z Venture different from other investors?
A2Z Venture specializes in AI-driven healthcare innovations, collaborating with medical institutions and corporate partners to provide extensive support to its portfolio companies.
What is the geographic focus of A2Z Venture?
The firm is based in Canada and primarily invests in Canadian startups within the healthcare sector.
What is A2Z Venture's approach to post-investment involvement?
A2Z Venture collaborates closely with its portfolio companies, leveraging partnerships with medical institutions and corporate strategic partners to enhance growth and scalability.
What is the typical check size for investments?
While specific check sizes are not disclosed, A2Z Venture focuses on seed-stage investments, which typically range from $100,000 to $1 million.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.